• The number of prevalent cases of dementia in the countries under study will increase by 25% over the 10-year forecast period, from 17 million to 21 million.
  • Of the countries considered in this analysis, Japan has the highest prevalence of dementia: 146 per 1,000.
  • The average age of all prevalent cases of dementia in the countries under study is 82.
  • 68% of all prevalent cases of dementia in the countries under study are female.

Table of contents

  • Dementia - Epidemiology - Mature Markets
    • Introduction
      • Key Findings
        • Overview
          • Total Prevalence of Dementia per 1,000 People Aged 65+ in 2020 and 2030
          • Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Dementia over the Next Ten Years
          • Number of Additional Total Prevalent Cases of Dementia Incurred over 2020-2030 in the Countries Under Study
          • Total Prevalent Cases of Dementia by Severity
      • Epidemiology Data
      • Methods
        • Total Prevalent Cases
        • Total Prevalent Cases by Severity
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Dementia
          • Studies Excluded from the Analysis of Dementia
        • Risk/Protective Factors
          • Risk/Protective Factors for Dementia
        • Bibliography
          • Glossary

      Author(s): Chaitra Srinivas; Oliver Blandy, M.Sc.

      Chaitra Srinivas, M.P.H., Pharm.D., is an associate epidemiologist at DRG, part of Clarivate. Dr. Srinivas obtained a master’s degree in medical sciences with a major in public health epidemiology from the Karolinska Institute in Sweden. She obtained her doctor of pharmacy from Rajiv Gandhi University of Health Sciences in Bangalore, India. Before completing her postgraduate degree, she worked in pharmacovigilance and drug safety and as a clinical pharmacist.

      Oliver Blandy, M.Sc., is a senior epidemiologist at DRG, part of Clarivate. Before joining DRG, Oliver worked as a research assistant for Imperial College London, where he was the lead for several studies within an NIRH-funded research group investigating healthcare-associated infections and antimicrobial resistance. He holds an M.Sc. from the University of Bristol, where he specialized in nutrition, physical activity, and public health. He also holds a B.Sc. in chemistry and a postgraduate certificate in education, both from the University of Bristol.